{"id":"W2054399435","doi":"10.1016/s1873-9954(07)70080-0","title":"P068 NATALIZUMAB MAINTAINS REMISSION FOR 2 YEARS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE AND IN THOSE WITH PRIOR INFLIXIMAB EXPOSURE: RESULTS FROM AN OPEN-LABEL EXTENSION STUDY","year":2007,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Natalizumab; Infliximab; Crohn's disease; Medicine; Open label; Disease; Internal medicine; Extension (predicate logic); Gastroenterology; Adverse effect; Computer science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005701153,0.00020929,0.0003991469,0.000226334,0.0001883459,0.00008440303,0.0002342179,0.00008508666,0.00001676877],"category_scores_gemma":[0.00007767267,0.000160933,0.00001645963,0.000160751,0.00007495718,0.0005409148,0.0001458067,0.0002410987,5.746597e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009228246,"about_ca_system_score_gemma":0.0001541155,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006774727,"about_ca_topic_score_gemma":0.0006144563,"domain_scores_codex":[0.9983123,0.0001445916,0.0006471957,0.0003634795,0.0001299583,0.0004025011],"domain_scores_gemma":[0.9991293,0.00008947161,0.0003157117,0.000203145,0.0002018244,0.00006055367],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8492692,0.009442716,0.04866672,0.0000247103,0.0002615658,0.0007671184,0.01448875,0.0000570997,0.0004952012,0.00004256565,0.0001220551,0.07636231],"study_design_scores_gemma":[0.05195135,0.004553968,0.937285,0.0002788057,0.00004918765,0.00001012992,0.004571491,0.000006632451,0.0002305976,0.0001325086,0.0007116715,0.0002186613],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971185,0.0005942766,0.00007688939,0.00009006713,0.00008599229,0.001565287,0.0004515563,0.000004149076,0.0000133009],"genre_scores_gemma":[0.999242,0.00003536032,0.0002784887,0.0001512737,0.000004023655,0.00002431268,0.0001871892,0.00002046991,0.0000568699],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8886183,"threshold_uncertainty_score":0.6562657,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0167947458870927,"score_gpt":0.2927308397466874,"score_spread":0.2759360938595947,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}